R. SANDERS WILLIAMS - Corporate Board Profile

AMGEN INC

Filing Date	Source Excerpt
2017-04-06	Dr. Williams is President of Gladstone Institutes, a non-profit biomedical research enterprise.
2018-04-11	R. Sanders Williams is the Chief Executive Officer of Gladstone Foundation, a not-for-profit organization supporting the Gladstone Institutes, a non-profit biomedical research enterprise, and President Emeritus of Gladstone Institutes since 2018. Dr. Williams has been a Professor of Medicine at the University of California, San Francisco since 2010. Dr. Williams was both President of Gladstone Institutes and its Robert W. and Linda L. Mahley Distinguished Professor of Medicine, from 2010 to 2017. Prior to this, Dr. Williams served as Senior Vice Chancellor of the Duke University School of Medicine from 2008 to 2010 and Dean of the Duke University School of Medicine from 2001 to 2008. He was the founding Dean of the Duke-NUS Graduate Medical School, Singapore, from 2003 to 2008 and served on its Governing Board from 2003 to 2010. From 1990 to 2001, Dr. Williams was Chief of Cardiology and Director of the Ryburn Center for Molecular Cardiology at the University of Texas, Southwestern Medical Center. Dr. Williams has been a director of the Laboratory Corporation of America Holdings, a diagnostic technologies company, since 2007, serving on the Audit Committee and chairing the Quality and Compliance Committee. Dr. Williams was a director of Bristol-Myers Squibb Company, a pharmaceutical company, from 2006 until 2013. Dr. Williams has served on the board of directors of the Gladstone Foundation, a non-profit institution that is distinct from Gladstone Institutes, since 2012 and on the board of directors of Exploratorium, a non-profit science museum and learning center located in San Francisco, since 2011. Dr. Williams was elected to the National Academy of Medicine in 2002. Dr. Williams received his undergraduate degree from Princeton University and his doctorate from Duke University. The Board concluded that Dr. Williams should serve on the Board because of his broad medical and scientific background, including his leadership roles in domestic and academic science settings, his deep experience in cardiology, oversight of governance of multi-hospital healthcare provider systems, leadership and development of international medical programs in Asia, and prior industry board experience.
2019-04-08	R. Sanders Williams is the President Emeritus of Gladstone Institutes... Committees: Corporate Responsibility and Compliance, Governance and Nominating... Director Compensation Table: R. Sanders Williams total compensation 338,221.
2020-04-07	R. Sanders Williams is the President Emeritus of Gladstone Institutes... 2019 Director Compensation Table shows R. Sanders Williams with total compensation of $339,716.
2021-04-06	R. Sanders Williams is President Emeritus of Gladstone Institutes. Director since 2014. Committees: Corporate Responsibility and Compliance, Governance and Nominating. Director Compensation Table shows $340,414 total compensation.
2022-04-05	R. Sanders Williams is the President Emeritus of Gladstone Institutes... Committees: Corporate Responsibility and Compliance, Governance and Nominating... 2021 Director Compensation: Fees Earned or Paid in Cash $130,000, Stock Awards $209,970, All Other Compensation $20,165, Total $360,135.
2023-04-06	R. Sanders Williams is the President Emeritus of Gladstone Institutes. ... Committees: Corporate Responsibility and Compliance, Governance and Nominating ... 2022 Director Compensation: R. Sanders Williams 359,938 USD.